参考文献/References:
[1]Long AN,Dagogo-Jack S.Comorbidities of diabetes and hypertension: mechanisms and approach to target organ protection[J].J Clin Hypertens (Greenwich),2011,13(4):244-251.[2]Maggiore U,Budde K,Heemann U,et al.Long-term risks of kidney living donation: review and position paper by the ERA-EDTA DESCARTES working group[J].Nephrol Dial Transplant,2017,32(2):216-223.[3]van den Born JC,Hammes HP,Greffrath W,et al.Gasotransmitters in Vascular Complications of Diabetes[J].Diabetes,2016,65(2):331-345.[4]Alicic RZ,Rooney MT,Tuttle KR.Diabetic Kidney Disease: Challenges, Progress, and Possibilities[J].Clin J Am Soc Nephrol,2017,12(12):2032-2045.[5]Tabaei BP,Al-Kassab AS,Ilag LL,et al.Does microalbuminuria predict diabetic nephropathy?[J].Diabetes Care,2001,24(9):1560-1566.[6]Zhou R,Chen KK,Zhang J,et al.The decade of exosomal long RNA species: an emerging cancer antagonist[J].Mol Cancer,2018,17(1):75.[7]Chen J,Li P,Zhang T,et al.Review on Strategies and Technologies for Exosome Isolation and Purification[J].Front Bioeng Biotechnol,2022,9:811971.[8]Kalra H,Drummen GP,Mathivanan S.Focus on Extracellular Vesicles: Introducing the Next Small Big Thing[J].Int J Mol Sci,2016,17(2):170.[9]Doyle LM,Wang MZ.Overview of Extracellular Vesicles, Their Origin, Composition, Purpose, and Methods for Exosome Isolation and Analysis[J].Cells,2019,8(7):727.[10]van Balkom BW,Pisitkun T,Verhaar MC,et al.Exosomes and the kidney: prospects for diagnosis and therapy of renal diseases[J].Kidney Int,2011,80(11):1138-1145.[11]Ciardiello C,Cavallini L,Spinelli C,et al.Focus on Extracellular Vesicles: New Frontiers of Cell-to-Cell Communication in Cancer[J]. Int J Mol Sci,2016,17(2):175.[12]Lin S,Yu Z,Chen D,et al.Progress in Microfluidics-Based Exosome Separation and Detection Technologies for Diagnostic Applications[J].Small,2020,16(9):e1903916.[13]Wu X,Showiheen SAA,Sun AR,et al.Exosomes Extraction and Identification[J].Methods Mol Biol,2019,2054:81-91.[14]Lobb RJ,Becker M,Wen SW,et al.Optimized exosome isolation protocol for cell culture supernatant and human plasma[J].J Extracell Vesicles,2015,4:27031.[15]Royo F,Diwan I,Tackett MR,et al.Comparative miRNA Analysis of Urine Extracellular Vesicles Isolated through Five Different Methods[J].Cancers (Basel),2016,8(12):112.[16]Mol EA,Goumans MJ,Doevendans PA,et al.Higher functionality of extracellular vesicles isolated using size-exclusion chromatography compared to ultracentrifugation[J].Nanomedicine,2017,13(6):2061-2065.[17]Hung PH,Hsu YC,Chen TH,et al.Recent Advances in Diabetic Kidney Diseases: From Kidney Injury to Kidney Fibrosis[J]. Int J Mol Sci,2021,22(21):11857.[18]Djudjaj S,Boor P.Cellular and molecular mechanisms of kidney fibrosis[J].Mol Aspects Med,2019,65:16-36.[19]Wu XM,Gao YB,Cui FQ,et al.Exosomes from high glucose-treated glomerular endothelial cells activate mesangial cells to promote renal fibrosis[J].Biol Open,2016,5(4):484-491.[20]刘苏,徐巍龙,查敏,等.miR-296-5p在糖尿病肾病db/db小鼠血浆外泌体中的表达及功能[J].南京医科大学学报(自然科学版),2022,42(1):14-22.[21]Lee WC,Li LC,Ng HY,et al.Urinary Exosomal MicroRNA Signatures in Nephrotic, Biopsy-Proven Diabetic Nephropathy[J].J Clin Med,2020,9(4):1220.[22]Nikolic-Paterson DJ,Atkins RC.The role of macrophages in glomerulonephritis[J].Nephrol Dial Transplant,2001,16 Suppl 5:3-7.[23]Alicic RZ,Johnson EJ,Tuttle KR.Inflammatory Mechanisms as New Biomarkers and Therapeutic Targets for Diabetic Kidney Disease[J].Adv Chronic Kidney Dis,2018,25(2):181-191.[24]Lv LL,Feng Y,Wu M,et al.Exosomal miRNA-19b-3p of tubular epithelial cells promotes M1 macrophage activation in kidney injury[J].Cell Death Differ,2020,27(1):210-226.[25]Li S,Jia Y,Xue M,et al.Inhibiting Rab27a in renal tubular epithelial cells attenuates the inflammation of diabetic kidney disease through the miR-26a-5p/CHAC1/NF-kB pathway[J].Life Sci,2020,261:118347.[26]Kimura T,Isaka Y,Yoshimori T.Autophagy and kidney inflammation[J].Autophagy,2017,13(6):997-1003.[27]Ebrahim N,Ahmed IA,Hussien NI,et al.Mesenchymal Stem Cell-Derived Exosomes Ameliorated Diabetic Nephropathy by Autophagy Induction through the mTOR Signaling Pathway[J].Cells,2018,7(12):226.[28]Huang H,Liu H,Tang J,et al.M2 macrophage-derived exosomal miR-25-3p improves high glucose-induced podocytes injury through activation autophagy via inhibiting DUSP1 expression[J].IUBMB Life,2020,72(12):2651-2662.[29]Jin J,Shi Y,Gong J,et al.Exosome secreted from adipose-derived stem cells attenuates diabetic nephropathy by promoting autophagy flux and inhibiting apoptosis in podocyte[J].Stem Cell Res Ther,2019,10(1):95.[30]兰凯,张光伟,刘树义,等.骨化三醇对糖尿病肾病大鼠尿液Smad1水平的影响[J].医学信息,2021,34(1):75-77.[31]Gao C,Wang B,Chen Q,et al.Serum exosomes from diabetic kidney disease patients promote pyroptosis and oxidative stress through the miR-4449/HIC1 pathway[J].Nutr Diabetes,2021,11(1):33.[32]Xie Y,Jia Y,Cuihua X,et al.Urinary Exosomal MicroRNA Profiling in Incipient Type 2 Diabetic Kidney Disease[J].J Diabetes Res,2017,2017:6978984. [33]Turkmen K.Inflammation, oxidative stress, apoptosis, and autophagy in diabetes mellitus and diabetic kidney disease: the Four Horsemen of the Apocalypse[J].Int Urol Nephrol,2017,49(5):837-844.[34]Eissa S,Matboli M,Bekhet MM.Clinical verification of a novel urinary microRNA panal: 133b, -342 and -30 as biomarkers for diabetic nephropathy identified by bioinformatics analysis[J].Biomed Pharmacother,2016,83:92-99.[35]Jiang ZZ,Liu YM,Niu X,et al.Exosomes secreted by human urine-derived stem cells could prevent kidney complications from type I diabetes in rats[J].Stem Cell Res Ther,2016,7:24. [36]Mao R,Shen J,Hu X.BMSCs-derived exosomal microRNA-let-7a plays a protective role in diabetic nephropathy via inhibition of USP22 expression[J].Life Sci,2021,268:118937.[37]Duan YR,Chen BP,Chen F,et al.Exosomal microRNA-16-5p from human urine-derived stem cells ameliorates diabetic nephropathy through protection of podocyte[J].J Cell Mol Med,2021,25(23):10798-10813.[38]Zhu QJ,Zhu M,Xu XX,et al.Exosomes from high glucose-treated macrophages activate glomerular mesangial cells via TGF-β1/Smad3 pathway in vivo and in vitro[J].FASEB J,2019,33(8):9279-9290.[39]Sifuentes-Franco S,Padilla-Tejeda DE,Carrillo-Ibarra S,et al.Oxidative Stress, Apoptosis, and Mitochondrial Function in Diabetic Nephropathy[J].Int J Endocrinol,2018,2018:1875870.[40]Zhang Y,Le X,Zheng S,et al.MicroRNA-146a-5p-modified human umbilical cord mesenchymal stem cells enhance protection against diabetic nephropathy in rats through facilitating M2 macrophage polarization[J].Stem Cell Res Ther,2022,13(1):171.[41]Hao Y,Miao J,Liu W,et al.Mesenchymal Stem Cell-Derived Exosomes Carry MicroRNA-125a to Protect Against Diabetic Nephropathy by Targeting Histone Deacetylase 1 and Downregulating Endothelin-1[J].Diabetes Metab Syndr Obes,2021,14:1405-1418.
相似文献/References:
[1]陈淑雯.肾衰宁联合科素亚治疗早期糖尿病肾病的临床观察[J].医学信息,2018,31(05):20.[doi:10.3969/j.issn.1006-1959.2018.05.007]
CHEN Shu-wen.Clinical Observation on Early Diabetic Nephropathy Treated by Shenshuaining Combined with Kosu[J].Journal of Medical Information,2018,31(24):20.[doi:10.3969/j.issn.1006-1959.2018.05.007]
[2]何丽杰.中西医治疗糖尿病肾病的临床效果分析[J].医学信息,2018,31(10):149.[doi:10.3969/j.issn.1006-1959.2018.10.051]
HE Li-jie.Clinical Effect Analysis of Diabetic Nephropathy Treated by Chinese and Western Medicine[J].Journal of Medical Information,2018,31(24):149.[doi:10.3969/j.issn.1006-1959.2018.10.051]
[3]贺 伟,高 峰.24 h尿微量白蛋白、血清胱抑素C水平与血清肌酐、尿素水平在2型糖尿病肾病早期诊断的意义[J].医学信息,2018,31(11):151.[doi:10.3969/j.issn.1006-1959.2018.11.049]
HE Wei,GAO Feng.The Significance of 24 h Urinary Microalbumin,Serum Cystatin C and Serum Creatinine and Urea Levels in the Early Diagnosis of Type 2 Diabetic Nephropathy[J].Journal of Medical Information,2018,31(24):151.[doi:10.3969/j.issn.1006-1959.2018.11.049]
[4]黄秋菊.胱抑素C及脂蛋白α在早期糖尿病肾病诊断中的价值研究[J].医学信息,2018,31(14):57.[doi:10.3969/j.issn.1006-1959.2018.14.018]
HUANG Qiu-ju.The Value of Cystatin C and Lipoprotein α in the Diagnosis of Early Diabetic Nephropathy[J].Journal of Medical Information,2018,31(24):57.[doi:10.3969/j.issn.1006-1959.2018.14.018]
[5]陆新虹,温玉洁,胡 欣,等.α-硫辛酸对2型糖尿病肾病患者
血清内脂素的影响研究[J].医学信息,2018,31(14):60.[doi:10.3969/j.issn.1006-1959.2018.14.019]
LU Xin-hong,WEN Yu-jie,HU Xin,et al.Effect of α-lipoic Acid on Serum Visfatin in Patients with
Type 2 Diabetic Nephropathy[J].Journal of Medical Information,2018,31(24):60.[doi:10.3969/j.issn.1006-1959.2018.14.019]
[6]郑小鹏,辛 华.糖尿病肾病研究进展[J].医学信息,2018,31(16):26.[doi:10.3969/j.issn.1006-1959.2018.16.008]
ZHENG Xiao-peng,XIN Hua.Progress in the Study of Diabetic Nephropathy[J].Journal of Medical Information,2018,31(24):26.[doi:10.3969/j.issn.1006-1959.2018.16.008]
[7]李志俊,王 利,王 浩.姜黄素改善糖尿病肾病的作用机制研究[J].医学信息,2018,31(24):35.[doi:10.3969/j.issn.1006-1959.2018.24.010]
LI Zhi-jun,WANG Li,WANG Hao.Study on the Mechanism of Curcumin in Improving Diabetic Nephropathy[J].Journal of Medical Information,2018,31(24):35.[doi:10.3969/j.issn.1006-1959.2018.24.010]
[8]肖学秀.益气活血汤联合西药治疗早期糖尿病肾病的临床观察[J].医学信息,2019,32(02):166.[doi:10.3969/j.issn.1006-1959.2019.02.051]
XIAO Xue-xiu.Clinical Observation of Yiqi Huoxue Decoction Combined with Western Medicine in Treating Earlyn Diabetic Nephropathy[J].Journal of Medical Information,2019,32(24):166.[doi:10.3969/j.issn.1006-1959.2019.02.051]
[9]李在明,魏正强.外泌体在结直肠癌中的研究进展[J].医学信息,2019,32(03):42.[doi:10.3969/j.issn.1006-1959.2019.03.014]
LI Zai-ming,WEI Zheng-qiang.Research Progress of Exosomes in Colorectal Cancer[J].Journal of Medical Information,2019,32(24):42.[doi:10.3969/j.issn.1006-1959.2019.03.014]
[10]张国艳,张佳田,隋洪玉.糖尿病肾病大鼠动物模型建立及INF-α干预机制研究[J].医学信息,2019,32(05):101.[doi:10.3969/j.issn.1006-1959.2019.05.030]
ZHANG Guo-yan,ZHANG Jia-tian,SUI Hong-yu.Establishment of Animal Model of Diabetic Nephropathy Rats and Study of INF-α Intervention Mechanism[J].Journal of Medical Information,2019,32(24):101.[doi:10.3969/j.issn.1006-1959.2019.05.030]